Visceral adipose tissue area is an independent risk factor for hepatic steatosis

Journal of Gastroenterology and Hepatology (Australia) - Tập 23 Số 6 - Trang 900-907 - 2008
Byung‐Joo Park1, Yoon Jun Kim2, Donghee Kim2, Won Kim2, Yeon-Ji Jung2, Jung‐Hwan Yoon2, Chung Y. Kim2, Young M. Cho3, Se H Kim4, Kyoung Bun Lee5, Ja June Jang5, Hyo S. Lee2
1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
2Department of Internal Medicine and Liver Research Institute
3Division of Endocrinology and Metabolism
4Department of Radiology
5Department of Pathology, Seoul National University College of Medicine, Seoul, Korea

Tóm tắt

AbstractBackground and Aim: Recent data indicate that hepatic steatosis is associated with insulin resistance, dyslipidemia and obesity (especially central body fat distribution). There have been few studies on the correlation between biopsy‐proven hepatic steatosis and the above factors in a disease‐free population. The aim of the present study was to evaluate the relation between hepatic steatosis assessed by biopsy and clinical characteristics including regional fat distribution measured by computed tomography (CT) in living liver donors.Methods: Laboratory data, liver/spleen Hounsfield ratio (L/S ratio), regional fat distribution by CT and liver status by biopsy were evaluated retrospectively in a total of 177 living liver donors without a history of alcohol intake.Results: The unpairedt‐test showed that age, triglycerides (TG), high density lipoprotein, total cholesterol, alanine aminotransferase, body mass index, L/S ratio, visceral adipose tissue area (VAT) and subcutaneous adipose tissue area (SAT) were associated with hepatic steatosis. In the multiple logistic regression analysis, VAT (odds ratio 1.031, 95% CI 1.013–1.048,P < 0.01) and TG (odds ratio 1.012, 95% CI 1.004–1.020,P < 0.01) were independent risk factors of hepatic steatosis. Subgroup analysis also showed that VAT was an independent risk factor in men (odds ratio 1.022, 95% CI 1.003–1.041,P < 0.05) and women (odds ratio 1.086, 95% CI 1.010–1.168,P < 0.05).Conclusion: Our results suggest that visceral abdominal adiposity is correlated with hepatic steatosis in healthy living liver donors.

Từ khóa


Tài liệu tham khảo

10.1053/gast.2002.36572

10.1016/S0016-5085(99)70506-8

10.1111/j.1440-1746.2005.04086.x

10.1210/jc.2006-1010

10.2337/diabetes.49.5.749

10.1530/eje.0.1490543

Fishbein MH, 2006, Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease, J. Pediatr. Gastroenterol. Nutr., 42, 83, 10.1002/j.1536-4801.2006.tb00012.x

10.1210/edrv.21.6.0415

10.2337/diacare.24.12.2127

10.1097/00042737-200305000-00014

10.1055/s-2001-12930

10.1259/0007-1285-53-629-440

10.1016/S1590-8658(02)80111-6

10.1056/NEJM200102153440706

10.1136/pgmj.2005.042200

10.1111/j.1365-2559.2006.02416.x

10.1093/ajcn/36.1.172

Larsson B, 1991, Obesity, fat distribution and cardiovascular disease, Int. J. Obes., 15, 53

10.1046/j.1440-1746.2002.02846.x

10.1002/hep.20149

10.1016/0026-0495(93)90210-F

10.1007/s00535-006-1790-5

10.1136/gut.2003.036566

10.1097/00005176-199703000-00015

10.1210/jcem.87.7.8638

10.1210/jcem.87.7.8736

Adams LA, 2006, Diagnostic evaluation of nonalcoholic fatty liver disease, J. Clin. Gastroenterol., 40, S34

Lupsor M, 2005, Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy?, Rom. J. Gastroenterol., 14, 419

10.1053/gast.2002.35354

10.1016/S0730-725X(96)00224-X

10.1002/mrm.20825

10.1152/ajpendo.00064.2004

10.2214/ajr.156.2.1898804

10.1111/j.1572-0241.2002.06038.x

Petz D, 2003, Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin‐needle biopsy, Virchows Arch., 442, 238, 10.1007/s00428-002-0749-z

10.4321/S1130-01082006000200007

10.1023/A:1005661516165

10.2337/dc06-0455

10.1016/j.jhep.2007.02.007

10.1152/ajpendo.00117.2003

10.1093/ajcn/54.1.18

10.1093/ajcn/44.6.739

10.1007/BF00404332

10.1038/sj.ijo.0802545

10.1159/000469304

10.7326/0003-4819-137-1-200207020-00006

10.2337/diacare.27.6.1427

10.2337/diabetes.54.11.3140

10.1053/gast.2003.50004

10.2337/diacare.27.8.2027

10.1001/jama.287.3.356